[1] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
[2] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
[3] |
AN Yanxiao, JIAO Hanliang, QI Yanwei, ZHONG Zhiyong.
Effects of lncRNA PSMA3-AS1 on proliferation,migration and invasion of neuroblastoma cells by regulating the miR-186?5p/SOX4 axis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 715-721.
|
[4] |
ZHANG Tianyang, XIAO Wen, XIN Zhenjiang, XIE Junqing.
Analysis of screening results of early diagnosis and treatment program for colorectal cancer in rural areas Fengtai district,Beijing,2015—2022
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 447-453.
|
[5] |
FANG Liaoxin, KANG Xiaofeng, XUE Chunyuan, PAN Lu, CHEN Jiaxin, TANG Chuanhao, SUN Liying, XU Xiaojie, DU Yimeng .
Effects of Omicron variant XBB.. spike protein on biological function of human non-small cell lung cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 271-276.
|
[6] |
WEI Xiaohuan, SHAN Qianqian, LIU Yuanyuan.
Galectin-4 regulates PD-L1 and affects the function of CD8+T cells in killing liver cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 532-537.
|
[7] |
MO Han, LIU Hui, FENG Chao, XIE Yuanliang, WANG Qiuyan, LI Tianyu.
Role and clinical significance of androgen receptor-related gene scoring system in prognostic prediction of bladder cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 556-563.
|
[8] |
HUANG Chuntao, WEN Tianbin, LYU Sihui, LIANG Jinlan, WANG Qi.
Construction and validation of a prognostic model for cervical cancer based on tumor immune cycle-related genes
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(4): 398-405.
|
[9] |
ZHU Yongqi, ZHU Yan, SHENG Meihong, ZHANG Xiaojuan, LIU Hongbin, LI Li.
Expression of programmed death-ligand 1 and cancer-associated fibroblasts in breast cancer tissues and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(4): 411-416.
|
[10] |
ZHAO Guangqiang, XUE Tianhui, YAN Bing .
The value of the ratio of pre-operative platelet distribution width to tumor size in the prognosis of patients with non-metastatic lung adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 317-321.
|
[11] |
WU Lingjun, LIANG Cong, HUANG Ju, LI Jialin, HUANG Songling, CHEN Zhuying, HE Ping.
Inhibitory effect of compound cremastra appendiculata on growth of human breast cancer MDA-MB-231 cell xenografts in nude mice and a network pharmacological analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 298-303.
|
[12] |
LIU Huaying, XIA Xue, ZHANG Mengwei, LUO Qinqin.
Bisdemethoxycurcumin induces apoptosis and inhibits proliferation of non-small cell lung cancer cells by regulating HIF-1α-mediated senescence
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 291-297.
|
[13] |
CHEN Xuxia, YANG Xiaohui, CHEN Weiling, ZHOU Yufei, LI Kaiguo, QU Song.
Overexpression of nuclear apoptosis-inducing factor 1 enhances the radiosensitivity of nasopharyngeal carcinoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 272-277.
|
[14] |
GONG Jingjie, ZHANG Haibo, YANG Yi, CAO Jiayu, DING Nan, ZHAO Jun.
Influencing factors of quality of life in patients with advanced non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 322-327.
|
[15] |
WU Longjunyu, YE Chunhua, YAO Qingchun, LI Yuandong, ZHANG Chunyan.
Application values of two dicarboxyl acylcarnitines in hepatitis B virus related diseases based on targeted metabolomics
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 202-207.
|